-
Should you sell your Affirm stock?
Affirm, a buy-now-pay-later lender, is vulnerable to a downturn. Investors are losing their enthusiasm, says Matthew Partridge
-
Beeks – building the infrastructure behind global markets
Beeks Financial Cloud has carved out a lucrative global niche in financial plumbing with smart strategies, says Jamie Ward
-
Profits at the final frontier – how to invest in space
Getting into space has never been cheaper thanks to private firms and reusable technology. That has sparked something of a gold rush in related industries, says Matthew Partridge
-
Magnificent Seven earnings: record iPhone sales fail to boost Apple’s stock
Magnificent Seven earnings season continued with Apple’s results on 29 January. Record iPhone sales initially boosted Apple’s shares, but news about the next Fed chair erased gains.
-
UK dividends rose in final quarter of 2025, but share buybacks ate into investor payouts
Last year saw dividend growth continue to fall below pre-pandemic averages, against a backdrop of increasing share buybacks.
-
Three emerging-market stocks to diversify your portfolio
Opinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
Opinion -
Coface offers excess profit in an unloved sector
Coface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotech
Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
Share tips 2026: this week’s top stock picks
Share tips Share tips 2026: MoneyWeek’s roundup of the top stock picks this week – here’s what the experts think you should buy
Share tips
